‘Successful’ Chemo- and Radiotherapy prior to Radical Cystectomy Does Not Necessarily Correlate with Clinical Course in Small Cell Carcinoma of the Bladder

2005 ◽  
Vol 74 (3) ◽  
pp. 286-288 ◽  
Author(s):  
Takehiro Sejima ◽  
Ikuo Miyagawa
2016 ◽  
Vol 9 (3) ◽  
pp. 574-579 ◽  
Author(s):  
Ashita Ono ◽  
Yosuke Hirasawa ◽  
Mitsumasa Yamashina ◽  
Naoto Kaburagi ◽  
Takashi Mima ◽  
...  

Primary small-cell carcinoma arising from the bladder (SmCCB) is uncommon. It differs from urothelial carcinoma (UC), the most common type of bladder cancer, with respect to its cell of origin, biology, and prognosis. Biologically, prostatic SmCCB is much more aggressive than UC, and the prognosis for cases with distant metastasis is especially poor. We report here a case of primary SmCCB (cT3bN1M0) treated with radical cystectomy.


1992 ◽  
Vol 78 (6) ◽  
pp. 409-413 ◽  
Author(s):  
Maurizio Amichetti ◽  
Sebastiana Boi ◽  
Gianni Fellin ◽  
Sergio Maluta ◽  
Paolo Dalla Palma ◽  
...  

Undifferentiated small cell carcinoma of the bladder is a rare but aggressive subset of urinary tract neoplasms. Analogous to small-cell carcinoma of the lung, this tumor frequently exhibits neuroendocrine differentiation. We report the 92nd and 93rd case of small cell carcinoma of the bladder reported in the literature with characteristic cytologic, histologic, histochemical, and ultrastructural features. The patients were treated initially with chemotherapy, but after a brief clinical course died for progression of disease and for myocardial infarction, respectively. The pathologic and clinical features and therapeutic options of the cases described in the literature are reviewed.


2015 ◽  
Vol 22 (6) ◽  
pp. 549-554 ◽  
Author(s):  
Dharam Kaushik ◽  
Igor Frank ◽  
Stephen A Boorjian ◽  
John C Cheville ◽  
Manuel S Eisenberg ◽  
...  

2015 ◽  
Vol 94 (4) ◽  
pp. 401-405 ◽  
Author(s):  
Jairam R. Eswara ◽  
Niall M. Heney ◽  
Chin-Lee Wu ◽  
W. Scott McDougal

Background: Small cell carcinoma of the bladder is an uncommon but clinically aggressive disease. There is no standard surgical or medical management for the disease. Methods: Between 1995 and 2009, 28 patients underwent transurethral resection (TUR) and/or cystectomy, chemotherapy, and/or radiation for small cell carcinoma of the bladder at our institution. Results: The median follow-up for survivors was 34 months. Patients presented most often with muscle-invasive disease (T2-4 - 89%), and 21% had lymph node/distant metastases. Tobacco use and chemical exposure were noted in 64 and 4% of patients, respectively. Patients with T1-2N0M0 had a median survival of 22 months compared to 8 months for those with more advanced disease (p = 0.03). Patients with T3-4 or nodal/metastatic disease who were given chemotherapy had an improved survival compared to those with T3-4 or nodal/metastatic disease who did not undergo chemotherapy (13 vs. 4 months, p = 0.005). The median time to recurrence of the entire cohort was 8 months, overall and cancer-specific survival was 14 months, and 5-year survival was 11%. Conclusions: Small cell carcinoma of the bladder is an aggressive disease with poor outcomes. Patients with T1-2N0M0 disease survived longer than those with advanced disease. Patients with T3-4 or nodal/metastatic disease had improved survival with chemotherapy.


2014 ◽  
Vol 191 (2) ◽  
pp. 329-334 ◽  
Author(s):  
Sanjay G. Patel ◽  
C.J. Stimson ◽  
Harras B. Zaid ◽  
Matthew J. Resnick ◽  
Michael S. Cookson ◽  
...  

2001 ◽  
Vol 165 (1) ◽  
pp. 186-187 ◽  
Author(s):  
LI-JEN WANG ◽  
YON-CHEONG WONG ◽  
YANG-JEN CHIANG ◽  
CHI-JEN CHEN

2019 ◽  
Vol 39 (4) ◽  
pp. 400-402
Author(s):  
Hyein Kang ◽  
Do-Hoon Kim ◽  
Wonmok Lee ◽  
Jungsook Ha ◽  
Namhee Ryoo ◽  
...  

1992 ◽  
Vol 78 (3) ◽  
pp. 207-210 ◽  
Author(s):  
Ilan-Gil Ron ◽  
Nelly Wigler ◽  
Bianca Ilie ◽  
Samario Chaitchik

Small cell carcinoma of the gall bladder is a rare tumor. The neoplasm is highly lethal, metastasizes early, and may cause death shortly after diagnosis. An oat cell carcinoma of the gallbladder metastatic to the liver and adjacent lymph nodes is described in a 60-year-old male. Partial cholecystectomy was performed followed by aggressive chemotherapy with etoposide and cisplatinum. An 80 % reduction in the size of the unexcised tumor was noted over a period of 6 months. The partial response and the relatively long survival of the patient suggest the use of the above protocol for these rare cases.


Sign in / Sign up

Export Citation Format

Share Document